Key findings: 12 mg dose: Average weight loss of 24.2% of body weight (approximately 58 lbs for a 240 lb individual) 8 mg dose: Average weight loss of 22.8% 4 mg dose: Average weight loss of 17.0% Placebo: Average weight loss of 2.1% Over 90% of participants receiving the 8 mg or 12 mg dose lost at least 10% of body weight Over 75% of participants at the highest dose lost at least 20% of body weight Significant improvements in waist circumference, blood pressure, and lipid profiles were observed across dose groups Phase 2 Trial in Type 2 Diabetes A separate phase 2 trial evaluated retatrutide in adults with type 2 diabetes and obesity (Rosenstock et al., Lancet , 2023)
From a practical standpoint, women need consistency over perfection, progressive challenge, adequate recovery, realistic timelines (meaningful changes take 12 to 16 weeks), and community support
A previous study from our lab showed that primary lung fibroblasts isolated from aged mice have a senescent phenotype [18]
Interestingly, a couple of Parkinsons drugs are derived from ergot
The combination of these peptides may enhance overall fat metabolism, making them effective for body recomposition
For tirzepatide , it is even slightly lower at around 48 kcal per day per kilogram